ResMed Inc. (LON:0KW4)
London
· Delayed Price · Currency is GBP · Price in USD 243.34
-2.34 (-0.95%)
At close: May 9, 2025
ResMed Ratios and Metrics
Market cap in millions GBP. Fiscal year is July - June.
Millions GBP. Fiscal year is Jul - Jun.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | May '25 May 8, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2015 - 2019 |
| Market Capitalization | 27,489 | 22,248 | 25,286 | 25,257 | 25,996 | 22,433 | Upgrade
|
| Market Cap Growth | 10.27% | -12.02% | 0.11% | -2.84% | 15.88% | 62.92% | Upgrade
|
| Enterprise Value | 27,409 | 22,966 | 26,454 | 25,761 | 26,440 | 23,365 | Upgrade
|
| Last Close Price | 188.46 | 149.71 | 169.00 | 170.35 | 172.67 | 141.57 | Upgrade
|
| PE Ratio | 27.04 | 27.54 | 35.80 | 39.38 | 75.67 | 44.68 | Upgrade
|
| PS Ratio | 7.07 | 6.00 | 7.61 | 8.58 | 11.23 | 9.39 | Upgrade
|
| PB Ratio | 6.40 | 5.78 | 7.78 | 9.13 | 12.44 | 11.12 | Upgrade
|
| P/TBV Ratio | 15.67 | 18.30 | 39.81 | 28.46 | 63.52 | 175.21 | Upgrade
|
| P/FCF Ratio | - | 21.60 | 56.02 | 141.88 | 56.63 | 39.29 | Upgrade
|
| P/OCF Ratio | - | 20.07 | 46.35 | 87.40 | 48.73 | 34.62 | Upgrade
|
| EV/Sales Ratio | 7.21 | 6.20 | 7.96 | 8.75 | 11.42 | 9.78 | Upgrade
|
| EV/EBITDA Ratio | 19.96 | 18.93 | 26.02 | 27.80 | 35.49 | 31.35 | Upgrade
|
| EV/EBIT Ratio | 22.42 | 20.97 | 29.18 | 31.24 | 39.80 | 35.76 | Upgrade
|
| EV/FCF Ratio | 22.57 | 22.30 | 58.60 | 144.71 | 57.60 | 40.92 | Upgrade
|
| Debt / Equity Ratio | 0.15 | 0.18 | 0.38 | 0.27 | 0.28 | 0.52 | Upgrade
|
| Debt / EBITDA Ratio | 0.46 | 0.56 | 1.19 | 0.79 | 0.75 | 1.37 | Upgrade
|
| Debt / FCF Ratio | 0.54 | 0.67 | 2.75 | 4.24 | 1.25 | 1.84 | Upgrade
|
| Asset Turnover | 0.70 | 0.69 | 0.71 | 0.73 | 0.69 | 0.68 | Upgrade
|
| Inventory Turnover | 2.09 | 1.87 | 1.84 | 2.30 | 2.97 | 3.10 | Upgrade
|
| Quick Ratio | 2.06 | 1.18 | 1.23 | 1.28 | 1.01 | 1.57 | Upgrade
|
| Current Ratio | 3.41 | 2.59 | 3.12 | 2.80 | 1.73 | 2.53 | Upgrade
|
| Return on Equity (ROE) | 25.81% | 22.70% | 23.96% | 24.96% | 17.63% | 27.21% | Upgrade
|
| Return on Assets (ROA) | 14.01% | 12.70% | 12.15% | 12.75% | 12.31% | 11.63% | Upgrade
|
| Return on Capital (ROIC) | 16.54% | 15.11% | 14.42% | 15.74% | 15.34% | 14.17% | Upgrade
|
| Return on Capital Employed (ROCE) | 24.30% | 23.20% | 19.20% | 22.70% | 24.00% | 20.30% | Upgrade
|
| Earnings Yield | 3.70% | 3.63% | 2.79% | 2.54% | 1.32% | 2.24% | Upgrade
|
| FCF Yield | 4.42% | 4.63% | 1.79% | 0.70% | 1.77% | 2.54% | Upgrade
|
| Dividend Yield | 0.67% | 1.01% | 0.82% | 0.81% | 0.67% | 0.89% | Upgrade
|
| Payout Ratio | 23.14% | 27.65% | 28.78% | 31.48% | 47.78% | 36.21% | Upgrade
|
| Buyback Yield / Dilution | 0.07% | -0.06% | -0.28% | -0.40% | -0.55% | -0.81% | Upgrade
|
| Total Shareholder Return | 0.75% | 0.95% | 0.54% | 0.41% | 0.12% | 0.08% | Upgrade
|
Updated Jan 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.